QOP
BIIB icon

Quinn Opportunity Partners’s Biogen BIIB Stock Holding History

Quinn Opportunity Partners’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-41,511
Closed -$11.7M – 205
2021
Q3 		$11.7M Buy
41,511
+2,000
+5% +$656K 0.75% 30
2021
Q2 		$13.7M Buy
39,511
+7,374
+23% +$2.23M 0.85% 27
2021
Q1 		$8.99M Buy
32,137
+21,037
+190% +$5.67M 0.57% 40
2020
Q4 		$2.72M Buy
+11,100
New +$2.86M 0.23% 83
2019
Q2 		– Sell
-2,000
Closed -$473K – 193
2019
Q1 		$473K Buy
+2,000
New +$630K 0.06% 124

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Quinn Opportunity Partners's BIIB Position: Q4 2021 in Review

Quinn Opportunity Partners sold out of Biogen (BIIB) in Q4 2021, closing a stake of 41,511 shares — an estimated $11.7M sold.

Quinn Opportunity Partners first reported a position in BIIB in Q1 2019 and held it in 5 quarters. The position peaked at $13.7M in Q2 2021. 1,009 funds tracked by Wall St. Rank hold BIIB as of Q4 2021.

  • Quinn Opportunity Partners reported no remaining Biogen position as of Q4 2021 after selling out during the quarter.
  • Quinn Opportunity Partners sold 41,511 Biogen shares in Q4 2021, an estimated $11.7M.
  • Quinn Opportunity Partners first reported a position in Biogen in Q1 2019 and held it in 5 quarters.
  • Quinn Opportunity Partners's Biogen position peaked at $13.7M in Q2 2021.
  • 1,009 funds tracked by Wall St. Rank held Biogen as of Q4 2021.

Based on Quinn Opportunity Partners's 13F filing for Q4 2021, filed 14 Feb 2022.